Covered recipient · General Payments record
ALISON PEDEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,140.21
- Reported across 126 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $462.67 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $205.98 | 11 |
| Amgen Inc. | $59.94 | 4 |
| Novo Nordisk AS | $42.47 | 2 |
| GlaxoSmithKline, LLC. | $33.64 | 2 |
| Sumitomo Pharma America, Inc. | $30.48 | 2 |
| Xeris Pharmaceuticals, Inc. | $25.32 | 1 |
| Mylan Specialty L.P. | $24.50 | 1 |
| ITI, Inc. | $23.92 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.46 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107828660 | CMS |
| ABBVIE INC. | $3.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107828662 | CMS |
| ABBVIE INC. | $6.06 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107828664 | CMS |
| ABBVIE INC. | $25.11 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107828666 | CMS |
| ABBVIE INC. | $25.62 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107828668 | CMS |
| ABBVIE INC. | $21.90 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107828670 | CMS |
| ABBVIE INC. | $5.18 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107828672 | CMS |
| ABBVIE INC. | $16.05 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107828674 | CMS |
| ABBVIE INC. | $5.13 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107828676 | CMS |
| ABBVIE INC. | $33.15 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107828678 | CMS |
| ABBVIE INC. | $32.09 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107828680 | CMS |
| Amgen Inc. | $13.95 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116008953 | CMS |
| Amgen Inc. | $18.28 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116008946 | CMS |
| Amgen Inc. | $14.39 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116008959 | CMS |
| Amgen Inc. | $13.32 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117652430 | CMS |
| GlaxoSmithKline, LLC. | $16.42 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116580123 | CMS |
| GlaxoSmithKline, LLC. | $17.22 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116108690 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23.92 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143580500 | CMS |
| Mylan Specialty L.P. | $24.50 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147344820 | CMS |
| Novo Nordisk Inc | $22.04 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100465978 | CMS |
| Novo Nordisk Inc | $20.43 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100651315 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.42 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151195859 | CMS |
| Sumitomo Pharma America, Inc. | $14.15 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148987172 | CMS |
| Sumitomo Pharma America, Inc. | $16.33 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148987174 | CMS |
| Xeris Pharmaceuticals, Inc. | $25.32 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144619017 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.